Metatrace

Sodium fluoride, the active ingredient in Metatrace, is a fluoride agent presented as an intravenous solution for systemic use. It is employed to correct fluoride deficiency and to support bone mineralization in appropriate clinical contexts. The formulation provides controlled delivery of fluoride ions, allowing rapid restoration of serum fluoride levels under medical supervision.

GNH USA supplies Metatrace as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Metatrace (sodium fluoride) is used in clinical situations that require systemic fluoride supplementation. - Fluoride deficiency: restores normal serum fluoride concentrations to support enamel and bone health. - Dental caries prevention (adjunct): provides systemic fluoride to enhance enamel resistance when topical measures are insufficient. - Metabolic bone disease (selected cases): contributes to bone mineralization under specialist supervision.

Intravenous sodium fluoride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Headache - Injection site pain

Serious or Rare Side Effects: - Hypocalcemia - Cardiac arrhythmia - Severe allergic reaction (anaphylaxis) - Fluorosis (high‑dose toxicity)

When using Metatrace, clinicians should observe several precautionary measures to minimize risk. - Renal function assessment: evaluate kidney function before and during therapy. - Electrolyte monitoring: check serum calcium and phosphate levels regularly. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Concomitant calcium supplements: avoid high‑dose calcium products that may reduce fluoride uptake. - Drug interactions: review patient medication list for agents that affect fluoride metabolism. - Store at below 25°C: keep in original container, protect from light and moisture.

Sodium fluoride can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Calcium‑containing antacids: reduce fluoride absorption. - High‑dose calcium supplements: may precipitate fluoride and diminish effect. - Aluminum or magnesium antacids: bind fluoride ions, decreasing bioavailability. - Tetracycline antibiotics: form insoluble complexes, lowering effectiveness of both agents.

Moderate Interactions (Monitor Closely): - NSAIDs: combined renal stress may increase risk of kidney injury. - Loop diuretics: may enhance electrolyte disturbances, especially hypocalcemia. - Vitamin D analogues: synergistic effect on calcium metabolism requiring monitoring. - ACE inhibitors: potential for altered renal handling of fluoride.